•
-
AIxBIO
Data Factories: Building the Infrastructure for AI-Ready Biology
Biology is entering an AI-driven era, but most experimental infrastructure still produces data designed for individual experiments, not for learning at scale. As a result, much of today’s data is useful in the moment but poorly suited for training robust, long-lived models. This session will explore what biological data matters most today, what data needs to be generated now to support future models, and how leading teams are closing that gap. Panelists will discuss how automation, metadata discipline, and standardized testing pipelines can turn artisanal lab workflows into continuous experiment-to-learning systems. The focus will be on infrastructure and experimental design, highlighting practical bottlenecks, emerging best practices, and what becomes possible when biology produces abundant, high-quality, model-ready data by default.
Featuring

Ori Zakin
BioRaptor
CEO
Building bioprocess R&D operating systems from noisy data.

Michael Koeris
DARPA
Director, BTO
Protecting National Security with Biology

Chase Olle
Robot on Rails
Founder & CEO
MIT-trained lab-robotics founder automating bench experiments at scale.

Michelle Chen
Form Bio
Pres, CEO & Board Mem.

Barry Bunin
CDD
Founder & CEO
Invented CDD Vault, data-sharing platform for drug discovery.
•
-
AIxBIO
Data Factories: Building the Infrastructure for AI-Ready Biology
Biology is entering an AI-driven era, but most experimental infrastructure still produces data designed for individual experiments, not for learning at scale. As a result, much of today’s data is useful in the moment but poorly suited for training robust, long-lived models. This session will explore what biological data matters most today, what data needs to be generated now to support future models, and how leading teams are closing that gap. Panelists will discuss how automation, metadata discipline, and standardized testing pipelines can turn artisanal lab workflows into continuous experiment-to-learning systems. The focus will be on infrastructure and experimental design, highlighting practical bottlenecks, emerging best practices, and what becomes possible when biology produces abundant, high-quality, model-ready data by default.
Featuring

Ori Zakin
BioRaptor
CEO
Building bioprocess R&D operating systems from noisy data.

Michael Koeris
DARPA
Director, BTO
Protecting National Security with Biology

Chase Olle
Robot on Rails
Founder & CEO
MIT-trained lab-robotics founder automating bench experiments at scale.

Michelle Chen
Form Bio
Pres, CEO & Board Mem.

Barry Bunin
CDD
Founder & CEO
Invented CDD Vault, data-sharing platform for drug discovery.
SynBioBeta is where the people building with biology meet the people funding, buying, and partnering with them. If you're raising capital, scouting the next wave of AIxBIO companies, or looking for your next technology partner - the people you need are here for three days.
The startups on stage this year are building programmable RNA medicines, virtual cell models, AI-designed enzymes, and proteins that replace sugar - alongside GSK, Sanofi, Novo Nordisk, Eli Lilly, J&J, Mars, Apple, Google, NVIDIA, Unilever, and P&G.
Watching where the partnerships form and which technologies the biggest players are actually evaluating is something you can't get from a report or a webinar. And our 1:1 Partnering App lets you book meetings before you arrive.
“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”
“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”

Eric Schmidt
Former CEO

"For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta."

Celestine Schnugg
Founder

"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."
"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."

Surge Biswas
Founder

"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."
"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."

Jacob Glanville
Founder & CEO

"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."
"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."

Bill Tai
Co-founder
"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."
"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."

Luis Cascao-Pereira
Head of Digital Biology

"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."
"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."

Ola Wlodek
CEO






















































































































